STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,120 | -75.7% | 538 | -34.5% | 0.00% | – |
| Q2 2023 | $8,727 | +16.3% | 821 | -8.9% | 0.00% | – |
| Q1 2023 | $7,505 | +65.6% | 901 | +83.5% | 0.00% | – |
| Q4 2022 | $4,532 | -74.8% | 491 | -65.8% | 0.00% | – |
| Q3 2022 | $18,000 | -10.0% | 1,435 | -5.2% | 0.00% | – |
| Q2 2022 | $20,000 | +150.0% | 1,514 | +317.1% | 0.00% | – |
| Q1 2022 | $8,000 | +166.7% | 363 | +200.0% | 0.00% | – |
| Q4 2021 | $3,000 | -85.0% | 121 | -79.8% | 0.00% | – |
| Q3 2020 | $20,000 | +42.9% | 600 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q1 2020 | $14,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |